24 October 2012 Size control of ferrimagnetic iron oxide nanocubes to achieve optimum static dephasing regime r2 relaxivity for in vivo MRI
Author Affiliations +
Proceedings Volume 8548, Nanosystems in Engineering and Medicine; 85482X (2012) https://doi.org/10.1117/12.999330
Event: SPIE Nanosystems in Engineering + Medicine, 2012, Incheon, Korea, Republic of
Abstract
Ferrimagnetic nanoparticles have been limited in in vivo application because nanoparticles aggregate due to its remanent magnetization. Uniform-sized ferromagnetic iron oxide nanocubes with similar value of bulk saturated magnetization were synthesized. Control of nanocubes’ size minimized their remanence. PEG-phospholipid encapsulation enabled spacing to prevent the aggregation. As a result, water-dispersed single core ferrimagnetic iron oxide nanocubes were successfully prepared and their r2 relaxivity was 761 s-1mM-1. It was very close to theoretical calculated value 800 s-1mM-1 in static dephasing regime. in vivo MR images were obtained after intravenous injection of 22 nm nanoparticles to a mouse. The MR signal of tumor site changed significantly. In this research, synthesized ferrimagnetic iron oxide nanocubes showed a superior T2 contrast effect and it would be able to improve the quality of early diagnosis and detection of tumor.
© (2012) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Youjin Lee, Nohyun Lee, Mihyun Park, Seung Hong Choi, Taeghwan Hyeon, "Size control of ferrimagnetic iron oxide nanocubes to achieve optimum static dephasing regime r2 relaxivity for in vivo MRI", Proc. SPIE 8548, Nanosystems in Engineering and Medicine, 85482X (24 October 2012); doi: 10.1117/12.999330; https://doi.org/10.1117/12.999330
PROCEEDINGS
6 PAGES


SHARE
Back to Top